MCM
Marathon Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.7M | Buy |
72,025
+2,830
| +4% | +$185K | 1.2% | 24 |
|
|
2025
Q1 | $4.63M | Sell |
69,195
-700
| -1% | -$46.9K | 1.23% | 26 |
|
|
2024
Q4 | $3.86M | Sell |
69,895
-150
| -0.2% | -$8.29K | 0.97% | 30 |
|
|
2024
Q3 | $4.18M | Sell |
70,045
-250
| -0.4% | -$14.9K | 1.01% | 27 |
|
|
2024
Q2 | $4.48M | Sell |
70,295
-875
| -1% | -$55.7K | 1.14% | 19 |
|
|
2024
Q1 | $4.92M | Buy |
71,170
+1,350
| +2% | +$93.3K | 1.17% | 25 |
|
|
2023
Q4 | $3.85M | Sell |
69,820
-1,850
| -3% | -$102K | 0.97% | 29 |
|
|
2023
Q3 | $4.16M | Buy |
71,670
+3,025
| +4% | +$176K | 1.05% | 28 |
|
|
2023
Q2 | $3.7M | Sell |
68,645
-16,245
| -19% | -$874K | 0.91% | 30 |
|
|
2023
Q1 | $3.37M | Buy |
84,890
+12,000
| +16% | +$477K | 0.83% | 32 |
|
|
2022
Q4 | $2.93M | Hold |
72,890
| – | – | 0.81% | 28 |
|
|
2022
Q3 | $2.34M | Sell |
72,890
-1,570
| -2% | -$50.5K | 0.67% | 35 |
|
|
2022
Q2 | $2.21M | Sell |
74,460
-550
| -0.7% | -$16.3K | 0.71% | 32 |
|
|
2022
Q1 | $2.11M | Buy |
75,010
+240
| +0.3% | +$6.75K | 0.61% | 41 |
|
|
2021
Q4 | $3.45M | Buy |
74,770
+575
| +0.8% | +$26.5K | 0.81% | 31 |
|
|
2021
Q3 | $2.44M | Buy |
+74,195
| New | +$2.44M | 0.55% | 37 |
|